Advertisement
Home Tags Liver Disease: Misc.

Tag: Liver Disease: Misc.

For patients with Child-Pugh B and C

Propranolol Use Tied to Increased Mortality in Child-Pugh B, C

0
Propranolol use beyond six months linked to increased mortality in Child-Pugh C with ascites
For patients with acute liver failure

Recent Improvement in Survival for Acute Liver Failure

0
From 1998 to 2013, improvement in overall, transplant-free survival in patients with ALF
Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare

FDA Approves First Tx for Disease Linked to Stem Cell Transplant

0
Hepatic veno-occlusive disease is rare, but fatal
For postmenopausal women with nonalcoholic fatty liver disease

Duration of Estrogen Deficiency Linked to Fibrosis Risk in NAFLD

0
Findings in postmenopausal women with nonalcoholic fatty liver disease
For patients with nonalcoholic fatty liver disease

MRI More Accurate Than Transient Elastography for NAFLD

0
Better diagnostic performance for MRI- versus TE-based measurements for liver fibrosis, steatosis
Chinese herbal medicine and Western medicine have different effects as causes of drug-induced liver injury

Drug-Induced Liver Injury From Chinese, Western Meds Varies

0
Cases caused by Chinese herbal medicine have more hepatocellular injury and higher mortality
Regular coffee consumption seems to delay disease progression in alcoholic liver disease and primary sclerosing cholangitis patients with end-stage liver disease and increase long-term survival following liver transplantation

Drinking Coffee May Slow Progression of Liver Disease

0
Appears to delay disease progression and increase post-transplantation survival
Curcumin exerts a hepatoprotective effect against acetaminophen-induced damage in mice

Curcumin May Help Prevent Liver Damage From Acetaminophen

0
Effect seen in histological, plasma analysis by preventing mitochondrial changes
For obese patients with type 2 diabetes mellitus

NAFLD Linked to Unfavorable Metabolic Profile in T2DM

0
More severe hyperinsulinemia, dyslipidemia, and adipose tissue/hepatic insulin resistance with NAFLD
Zepatier (elbasvir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis C virus genotypes 1 and 4 infections.

FDA Approves Zepatier for Chronic Hepatitis C

0
Medication indicated for patients with hepatitis C virus genotypes 1 and 4 infections